Paraganglioma Market to Reach $3.61 Billion by 2029, Expanding at 4.5% CAGR

 Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the paraganglioma sector.

 



 What Is The Expected CAGR For The Paraganglioma Market Through 2025?
 The paraganglioma market size has grown steadily in recent years. It will grow from $2.89 billion in 2024 to $3.02 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to advancements in diagnostic imaging, increasing awareness & screening programs, regulatory approvals for targeted therapies, growth in specialized treatment centers, and advancements in genetic testing.
 
 The paraganglioma market size is expected to see steady growth in the next few years. It will grow to $3.61 billion in 2029 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to emerging targeted therapies & immunotherapies, expansion of radiopharmaceuticals, rising prevalence of genetic disease, growing investments in rare disease research, and improved healthcare access in emerging markets. Major trends in the forecast period include advancements in targeted therapies, expansion of radiopharmaceuticals, the rise of immunotherapy approaches, improved artificial intelligence (AI) in diagnostics, and the development of minimally invasive surgical techniques.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=21245&type=smp
 
 Which Key Factors Will Influence Paraganglioma Market Growth Over 2025–2034?
 The increasing investments on oncology research and medicine is expected to propel the growth of the paraganglioma market going forward. Investments in oncology research and medicine refer to financial allocations made by governments, pharmaceutical companies, research institutions, and private investors to advance the understanding, prevention, diagnosis, and treatment of cancer. The increasing investments in oncology research and medicine are due to the rising global cancer burden, advancements in precision medicine, growing demand for innovative therapies, expanding clinical trials, government and private funding initiatives, and the development of targeted and immunotherapy treatments. Investments in oncology research and medicine support paraganglioma by driving advancements in early diagnosis, enhancing treatment options such as targeted therapies and immunotherapy, funding clinical trials for more effective drugs, improving pediatric cancer care infrastructure, and fostering innovative research to better understand the disease’s biology and progression. For instance, in May 2024, according to the IQVIA, an India-based information technology company providing advanced analytics, global spending on cancer medicine rose to $223 billion in 2023, marking a $25 billion increase from 2022, and is expected to reach $409 billion by 2028. Therefore, the increasing investments on oncology research and medicine drives the paraganglioma market.
 
 Comprehensive Segment-Wise Insights Into The Paraganglioma Market
 The paragangliomamarket covered in this report is segmented — 
 
 1) By Type: Sympathetic Paragangliomas; Parasympathetic Paragangliomas; Caroid Paragangliomas; Cervical Paragangliomas; Jugular Paragangliomas; Secretory Paragangliomas; Temporal Paragangliomas
 2) By Origin: Head And Neck; Abdomen; Pelvis; Other Origins
 3) By Treatment Type: Peptide Receptor Radionuclide Therapy; Surgery; Chemotherapy; Radiation Therapy; Other Treatment Types
 4) By Distribution Channel: Hospital Pharmacies; Drug Stores And Retail Pharmacies; Online Pharmacies
 5) By End-User: Hospitals; Specialty Clinics; Cancer Research Institutes; Other End-Users
 
 Subsegments:
 1) By Sympathetic Paragangliomas: Adrenal Sympathetic Paragangliomas; Extra-Adrenal Sympathetic Paragangliomas 
 2) By Parasympathetic Paragangliomas: Head And Neck Parasympathetic Paragangliomas; Thoracic Parasympathetic Paragangliomas 
 3) By Carotid Paragangliomas: Unilateral Carotid Paragangliomas; Bilateral Carotid Paragangliomas 
 4) By Cervical Paragangliomas: Vagal Paragangliomas; Hypoglossal Paragangliomas 
 5) By Jugular Paragangliomas: Type A; Type B; Type C; Type D 
 6) By Secretory Paragangliomas: Catecholamine-Secreting Paragangliomas; Non-Catecholamine-Secreting Paragangliomas 
 7) By Temporal Paragangliomas: Tympanic Paragangliomas; Mastoid Paragangliomas
 
 What Are The Prominent Trends In The Paraganglioma Market?
 Major companies operating in the paraganglioma market are focusing on developing advanced therapies such as oral hypoxia-inducible factor-2 alpha (HIF-2a) inhibitors to offer targeted therapy options for patients with paraganglioma. An oral HIF-2a inhibitor is a targeted therapy that suppresses HIF-2a activity, a key factor in tumor growth under low-oxygen conditions, helping to slow the progression of cancers like paraganglioma. For instance, in January 2025, Merck, a US-based biopharmaceutical company, announced a priority review for its supplemental new drug application for Welireg (belzutifan), which is granted by the U.S. Food and Drug Administration (FDA), a US-based government agency. It is designed for adult and pediatric patients (12 years and older) with advanced, unresectable, or metastatic pheochromocytoma and paraganglioma (PPGL). The sNDA is based on objective response rate (ORR) and duration of response (DOR) data from the Phase 2 LITESPARK-015 trial.
 
 Analysis Of Key Players In Paraganglioma Market
 Major companies operating in the paraganglioma market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc. , Mount Sinai, Penn Medicine, Stanford Health Care, St. Jude Children’s Research Hospital, UT Health San Antonio, The University of Chicago Medical Center, Fred Hutchinson Cancer Center, Florida Cancer Specialists & Research Institute, Invitae Corp., Clinigen Group plc, Fulgent Genetics, Dana-Farber Cancer Institute Inc., Oncology Hematology Care Inc., Enterome , National Institutes of Health Clinical Center, Progenics Pharmaceuticals Inc., Pheo Para Alliance, Saint John’s Cancer Institute 
 
 View the full paraganglioma market report here:
 https://www.thebusinessresearchcompany.com/report/paraganglioma-global-market-report
 
 What Are The Key Regional Trends In The Paraganglioma Market?
 North America was the largest region in the paraganglioma market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the paraganglioma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Global Next-Generation Advanced Batteries Market Outlook 2026-2030: Regional Growth and Sizing Insights

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.    How Is the Next-Generation Advanced Batteries Market Expected to Expand in Terms of Size and Growth?  The next-generation advanced batteries market size has grown rapidly in recent years. It will grow from $14.21 billion in 2025 to $15.93 billion in 2026 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to increasing adoption of electric vehicles, integration with renewable energy systems, the need for cost-effective alternatives to lithium-ion batteries, growing demand for energy storage solutions, government in...
Read more

Intense Pulsed Light (IPL) Facial Rejuvenation Device Industry Projected to Experience Accelerated Growth by 2029

Image
 Get 30% Off All Market Studies With Code ONLINE30 — Anticipate Tariff Impacts, Market Disruptors, and Long-Term Growth Trends    What Is the Intense Pulsed Light (IPL) Facial Rejuvenation Device Market Growth Potential Across Different Regions?  The intense pulsed light (IPL) facial rejuvenation device market size has grown rapidly in recent years. It will grow from $1.05 billion in 2024 to $1.18 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to growing influence of social media beauty standards, increasing preference for youthful appearance, rising penetration of aesthetic clinics, rise in technological adoption in dermatology practices, increasing awareness of early anti-aging treatments.    The intense pulsed light (IPL) facial rejuvenation device market size is expected to see rapid growth in the next few years. It will grow to $1.85 billion in 2029 at a compound annual growth rate ...
Read more

Global Aggregate Stockpile Drones Market Outlook 2026-2030: Regional Growth and Sizing Insights

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.    What Is the Forecasted Market Size of the Aggregate Stockpile Drones Market by 2030?  The aggregate stockpile drones market size has grown rapidly in recent years. It will grow from $1.04 billion in 2025 to $1.20 billion in 2026 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to growing need for accurate stockpile measurement, increasing adoption of drones in mining operations, rising focus on worker safety during surveying, expansion of quarry and aggregates production activities, growing shift from manual to ...
Read more